Publications by authors named "Keith D Lindor"

Claim this Profile
B
Betaine in the treatment of steatotic liver disease-Historical fad or a timeless treasure worth reviving?
Manal F Abdelmalek, Keith D Lindor

Hepatology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis.
Rozanne C de Veer, Maria C van Hooff, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Keith D Lindor

Am J Gastroenterol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival.
C Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, Palak J Trivedi, Christophe Corpechot, Keith D Lindor

Liver Int· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis.
Ahmad H Ali, Cynthia W Buness, Ryan Fischer, Gerald J Holtmann, Ayesha Shah, Keith D Lindor

Hepatology· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid.
Jessica T Hochberg, Aalam Sohal, Priya Handa, Bryan D Maliken, Take-Kyun Kim, Keith D Lindor

JHEP Rep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe.
Carla F Murillo Perez, Alessio Gerussi, Palak J Trivedi, Christophe Corpechot, Adriaan J van der Meer, Keith D Lindor

Eur J Gastroenterol Hepatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
C Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, Dorcas Kareithi, Femi Adekunle, Keith D Lindor

Gastroenterology· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid.
Rozanne C de Veer, Maren H Harms, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Keith D Lindor

Aliment Pharmacol Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of vidofludimus calcium for treatment of primary sclerosing cholangitis.
Elizabeth J Carey, John Eaton, Mitchell Clayton, Andrea Gossard, Sara Iqbal, Keith D Lindor

Hepatol Commun· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases.
Keith D Lindor, Christopher L Bowlus, James Boyer, Cynthia Levy, Marlyn Mayo

Hepatology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool.
Carla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, Palak J Trivedi, Adriaan J van der Meer, Keith D Lindor

Eur J Gastroenterol Hepatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta-analysis.
Tej I Mehta, Simcha Weissman, Brian M Fung, John Sotiriadis, Keith D Lindor

Liver Int· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis.
Alessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, Willem J Lammers, Henk Van Buuren, Keith D Lindor

Clin Gastroenterol Hepatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis.
Karim T Osman, Daniel B Maselli, Ilkay S Idilman, Daniel J Rowan, Jason K Viehman, Keith D Lindor

J Clin Gastroenterol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.
Jorn C Goet, Carla F Murillo Perez, Maren H Harms, Annarosa Floreani, Nora Cazzagon, Keith D Lindor

Am J Gastroenterol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of fibrates in cholestatic liver diseases.
Andres F Carrion, Keith D Lindor, Cynthia Levy

Liver Int· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis.
John E Eaton, Christopher L Welle, Zeinab Bakhshi, Shannon P Sheedy, Ilkay S Idilman, Keith D Lindor

Hepatology· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful response of primary sclerosing cholangitis and associated ulcerative colitis to oral vancomycin may depend on brand and personalized dose: report in an adolescent.
Cynthia W Buness, Kevin M Johnson, Ahmad Hassan Ali, Leina Alrabadi, Keith D Lindor

Clin J Gastroenterol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.
Ahmad Hassan Ali, Yan Bi, Jorge D Machicado, Sushil Garg, Ryan J Lennon, Keith D Lindor

J Gastroenterol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis.
Maren H Harms, Rozanne C de Veer, Willem J Lammers, Christophe Corpechot, Douglas Thorburn, Keith D Lindor

Gut· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis.
Ahmad Hassan Ali, Jennifer Damman, Shamita B Shah, Yinka Davies, Melissa Hurwitz, Keith D Lindor

Scand J Gastroenterol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase.
Carla F Murillo Perez, Maren H Harms, Keith D Lindor, Henk R van Buuren, Gideon M Hirschfield

Am J Gastroenterol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort.
Zeinab Bakhshi, Moira B Hilscher, Gregory J Gores, William S Harmsen, Jason K Viehman, Keith D Lindor

J Gastroenterol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapies for PBC.
David Maxwell Hunter Chascsa, Keith Douglas Lindor

J Gastroenterol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response.
Carla F Murillo Perez, Gideon M Hirschfield, Christophe Corpechot, Annarosa Floreani, Marlyn J Mayo, Keith D Lindor

Aliment Pharmacol Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis